Narrow your search

Library

KU Leuven (1)

UCLouvain (1)

UGent (1)

ULiège (1)

VUB (1)


Resource type

book (1)


Language

English (1)


Year
From To Submit

2002 (1)

Listing 1 - 1 of 1
Sort by
Contrast agents II : optical, ultrasound, X-ray and radiopharmaceutical imaging
Author:
ISSN: 03401022 ISBN: 3540422471 3540434518 354045733X 3540460098 9783540422471 9783540434511 Year: 2002 Volume: 222 Publisher: New York, NY ; Berlin : Springer-Verlag,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Extracellular MRI and X-ray contrast agents are characterized by their phar- cokinetic behaviour.After intravascular injection their plasma-level time curve is characeterized by two phases. The agents are rapidly distributed between plasma and interstitial spaces followed by renal elimination with a terminal half-live of approximatly 1–2 hours. They are excreted via the kidneys in unchanged form by glomerular filtration. Extracellular water-soluble contrast agents to be applied for X-ray imaging were introduced into clinical practice in 1923. Since that time they have proved to be most valuable tools in diagnostics.They contain iodine as the element of choice with a sufficiently high atomic weight difference to organic tissue. As positive contrast agents their attenuation of radiation is higher compared with the attenuation of the surrounding tissue. By this contrast enhancement X-ray diagnostics could be improved dramatically. In 2,4,6-triiodobenzoic acid derivatives iodine is firmly bound. Nowadays diamides of the 2,4,6-triiodo-5-acylamino-isophthalic acid like iopromide (Ultravist, Fig. 1) are used as non-ionic (neutral) X-ray contrast agents in most cases [1].

Listing 1 - 1 of 1
Sort by